Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2011 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Asset Utilization Ratio of 0.67 for Q1 2026, up 53.24% year-over-year from 0.44 in Q1 2025, and up 44.29% quarter-over-quarter from 0.46 in Q4 2025.
Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Sarepta Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.67 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 53.24% year-over-year to 0.67; the TTM figure through Mar 2026 stood at 0.67 (up 53.24% YoY), while the FY2025 annual figure was 0.51, down 3.12% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.67, up from 0.46 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.67 in Q1 2026, with the low at 0.18 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 0.5 (2024), against an average of 0.49.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio jumped 178.51% in 2023, then sank 31.3% in 2025.
- Sarepta Therapeutics' Asset Utilization Ratio stood at 0.48 in 2022, then climbed by 23.86% to 0.59 in 2023, then decreased by 14.74% to 0.5 in 2024, then retreated by 7.8% to 0.46 in 2025, then soared by 44.29% to 0.67 in 2026.
- Business Quant data shows SRPT's Asset Utilization Ratio at 0.67 in Q1 2026, 0.46 in Q4 2025, and 0.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 0.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.62 |
| Mar 31, 2026 | 0.67 |
| Dec 31, 2025 | 0.46 |
| Sep 30, 2025 | 0.50 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.44 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | 0.66 |
| Jun 30, 2024 | 0.65 |
| Mar 31, 2024 | 0.64 |
| Dec 31, 2023 | 0.59 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 0.51 |
| Mar 31, 2023 | 0.50 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.26 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.18 |
| Dec 31, 2021 | 0.18 |
| Sep 30, 2021 | 0.18 |